Morgan Stanley’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Morgan Stanley’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-621,945	Closed	-$1.86M	–	8316
2022 Q1	$1.86M	Buy	621,945 +505,412	+434%	+$1.11M	﹤0.01%	4566
2021 Q4	$149K	Sell	116,533 -7,352	-6%	-$14.7K	﹤0.01%	6220
2021 Q3	$279K	Buy	123,885 +22,999	+23%	+$82.6K	﹤0.01%	5819
2021 Q2	$575K	Buy	100,886 +97,786	+3,154%	+$651K	﹤0.01%	5444
2021 Q1	$19K	Sell	3,100 -21,739	-88%	-$163K	﹤0.01%	6747
2020 Q4	$195K	Buy	24,839 +21,935	+755%	+$194K	﹤0.01%	5602
2020 Q3	$29K	Buy	2,904 +2,783	+2,300%	+$28.7K	﹤0.01%	5926
2020 Q2	$1K	Buy	121 +21	+21%	+$208	﹤0.01%	6561
2020 Q1	$1K	Buy	+100	New	+$987	﹤0.01%	6522

Morgan Stanley's TLMD Position: Q2 2022 in Review

Morgan Stanley sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 621,945 shares — an estimated $1.86M sold.

Morgan Stanley first reported a position in TLMD in Q1 2020 and held it in 9 quarters. The position peaked at $1.86M in Q1 2022. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Morgan Stanley reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 621,945 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $1.86M.
Morgan Stanley first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2020 and held it in 9 quarters.
Morgan Stanley's SOC Telemed, Inc. Class A Common Stock position peaked at $1.86M in Q1 2022.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.